; Crk-associated substrate) was ®rst recognized over 10 years ago as a 130 kilodalton (kDa) phosphotyrosine (pTyr)-containing protein that associated with two oncoproteins, pp60
v-src (v-Src) and p47 gag-crk (v-Crk) (Matsuda et al., 1990; Reynolds et al., 1989) . Following cloning of the Rat cDNA in 1994 (Sakai et al., 1994a,b) , tremendous eorts have been placed on determining the function of Cas in both oncogenic and normal cellular processes. This review will begin with a short perspective on Cas and its family members. It will then discuss some of the known functions of Cas and explore possible mechanisms through which Cas may perform these functions. Finally, it will investigate potential roles for Cas in the development and/or progression of oncogenesis.
Cas and its family members
Cas was ®rst identi®ed as a pTyr-containing 130 kDa protein in cells transformed by the oncogenes v-src and v-crk (Matsuda et al., 1990; Reynolds et al., 1989) . Transformation by both of these oncogenes requires protein tyrosine kinase (PTK) activity; in the case of vSrc, PTK activity is provided by its own intrinsic catalytic activity (Jove and Hanafusa, 1987) , whereas expression of v-Crk induces the PTK activity of a heterologous kinase (Mayer et al., 1988; Mayer and Hanafusa, 1990a) . The 130 kDa protein (p130), which was later identi®ed as Cas, was found to associate with activated variants of cellular Src (c-Src, Src) and v-Crk (Matsuda et al., 1990 (Matsuda et al., , 1991 Mayer and Hanafusa, 1990a; Reynolds et al., 1989) . Mutations in v-Src and v-Crk that abrogated binding of this 130 kDa protein also abolished the transforming activity of these oncoproteins, suggesting that p130 played a critical role in the transformation process (Kanner et al., 1991; Mayer and Hanafusa, 1990b) .
A cDNA clone encoding Cas was isolated in 1994 (Sakai et al., 1994a,b) and its predicted domain structure suggested that it functioned as an adapter or scaolding molecule (Figure 1 ). Cas contains an amino-terminal src-homology 3 (SH3) domain, followed by a short proline-rich segment, a largè substrate-binding' domain containing ®fteen repeats of a four amino acid sequence (tyrosine-any two amino acids-proline; YXXP), a serine-rich region and a carboxy-terminal domain. The YXXP motif found in the substrate-binding domain can serve as a PTK substrate (Songyang, 2001; Songyang et al., 1994; Songyang and Cantley, 1998) , leading to phosphorylation of one or more tyrosine residues. Once phosphorylated, these tyrosine residues can then serve as ligands for src-homology 2 (SH2) or pTyr binding (PTB) domains contained in many dierent cellular proteins. Within the carboxy-terminal half of Cas, there are several additional protein interaction sites . The predicted function of Cas as an adapter protein has been borne out through the identi®cation of numerous binding partners ( Figure 1 ). While several of these interactions have been detected in vivo following activation of speci®c signaling pathways, the regulation and function of many Cas protein complexes remain unresolved.
There are two other family members that share considerable structure and sequence homology with Cas. Human enhancer of filamentation HEF1/CasL (HEF1) was identi®ed in 1996 as a`lymphocyte-type' Cas family member that promoted pseudohyphal growth in the budding yeast Saccharomyces cerevisiae (Law et al., 1996; Minegishi et al., 1996) . Embryonal Fyn-associated substrate (Efs)/Src-interacting protein (Sin) was identi®ed about the same time as a Fyn/Srcassociated protein (Alexandropoulos and Baltimore, 1996; Ishino et al., 1995) . Both HEF1 and Efs/Sin share a similar domain structure with Cas, with the greatest sequence similarity present in the SH3 domains and the carboxy-terminal 200 amino acids (Figure 2) . One of the most notable dierences between the functional sequence motifs of these proteins is found in the Src binding sequences. The bipartite binding site present in Cas and Efs/Sin includes a proline-rich region that binds to the Src SH3 domain and a pTyr-containing sequence that binds to the Src SH2 domain (Alexandropoulos and Baltimore, 1996; Burnham et al., 1999 Burnham et al., , 2000 Nakamoto et al., 1996) . The SH3-binding sequence is absent from HEF1 ( Figure 2 ). It is unclear how this change aects Src binding to HEF1, but Cas molecules with proline-to-alanine substitutions in these sequences exhibit reduced binding to Src (Burnham et al., 1999 (Burnham et al., , 2000 Nakamoto et al., 1996) .
While the three Cas family members share a common domain structure, several lines of evidence suggest that they have potentially distinct functions. First, the expression patterns of these three proteins dier signi®cantly. Whereas Cas mRNA and protein are expressed in most adult tissues, HEF1 mRNA levels are signi®cantly reduced in brain and liver, and HEF1 protein levels appear to be greatest in lymphocytes, lung and breast epithelium (Law et al., 1996 (Law et al., , 1998 Minegishi et al., 1996; Sakai et al., 1994a) . Expression of Efs/Sin is considerably more restricted, with the highest levels of mRNA being present in embryonic tissues (Ishino et al., 1995) . Second, there is some indication that the three family members may undergo distinct post-translational modi®cations and exhibit unique localization patterns within the cell. All three molecules are predominantly cytoplasmic, but a fraction of Cas and HEF1 is found in focal adhesions of adherent cells Law et al., 1996 Law et al., , 2000 Nakamoto et al., 1997; Petch et al., 1995; Polte and Hanks, 1995) . HEF1 undergoes a speci®c cleavage event during mitosis, culminating in the appearance of a biologically active amino-terminal fragment that localizes to the mitotic spindle (Law et al., 1998) . Cas also undergoes post-translational modi®cations during mitosis, characterized by a dramatic loss of tyrosine phosphorylation and a concomitant increase in serine phosphorylation (Yamakita et al., 1999) . Third, there is evidence to suggest that HEF1 and Efs/Sin are unable to genetically and/or functionally substitute for Cas during embryonic development. Mouse embryos con- Figure 1 Cas structure and its binding partners. A graphic depiction of the domain structure of Cas is shown, including the SH3 domain (SH3), proline-rich region (PRO), substrate-binding YXXP domain (YXXP 15 ), serine-rich region (SER) and carboxyterminus (C-terminus). The bipartite Src binding sequence is indicated by single letter amino acid codes; the Src SH3 domain binds to the sequence RPLPSPP beginning at residue 639 and the Src SH2 domain binds to the sequence motif pYDYV beginning at residue 668 . Proteins that have been shown to bind to the domains of Cas, either in vitro or in vivo, are presented below. A partial list of references that address binding of these proteins to Cas includes: Fak Harte et al., 1996; Polte and Hanks, 1995) , Pyk2 (Astier et al., 1997b; Lakkakorpi et al., 1999) , FRNK , PTP1B (Liu et al., 1996) , PTP-PEST (Garton et al., 1996) , C3G (Kirsch et al., 1998) , PR-39 (Chan and Gallo, 1998) , CMS (Kirsch et al., 1999; Nakamoto et al., 2000) , Crk Sakai et al., 1994a) , Nck (Schlaepfer et al., 1997) , PI3K (Li et al., 2000) , SHIP2 (Prasad et al., 2001 ), 14-3-3 (Garcia-Guzman et al., 1999 , Src family kinases Nakamoto et al., 1996; Sakai et al., 1994a) , NSP family members (Gotoh et al., 2000; Lu et al., 1999; Sakakibara and Hattori, 2000) , Grb2 , Nephrocystin (Donaldson et al., 2000) , PI3K (Li et al., 2000) , ID2 (Law et al., 1999) , CIZ (Nakamoto et al., 2000) Oncogene Functions of the adapter protein Cas AH Bouton et al taining a homozygous deletion of the cas gene do not survive embryogenesis, despite the fact that the genes encoding HEF1 and Efs/Sin are still present (Honda et al., 1998) . Cas 7/7 embryos obtained at embryonic day 11.5 ± 12.5 exhibit severe cardiovascular de®ciencies, which correlate with the appearance of defects in myo®bril and Z-disk organization in cardiocytes isolated from these animals. These studies indicate that the genes encoding HEF1 and Efs/Sin are not sucient to overcome the extensive structural abnormalities that occur as a consequence of the Cas de®ciency.
While Cas, HEF1 and Efs/Sin share structural and sequence homology, the data described above suggest that they may have distinct functions that arise from dierences in tissue distribution, subcellular localization, post-translational modi®cations and primary sequence divergence. The remainder of this review will focus predominantly on Cas, although other family members will be discussed in those cases where unique functions are suggested. For additional information about possible functions of Cas family members, readers are directed to a recent review by .
Regulation of the actin cytoskeleton and cell migration
The process of cell migration is functionally linked to cell-extracellular matrix (ECM) interactions. The ®rst hint that Cas played a role in this process came from studies demonstrating that Cas was present in subcellular structures called focal adhesions that form molecular bridges between the ECM and the actin cytoskeleton Nakamoto et al., 1997; Petch et al., 1995; Polte and Hanks, 1995 ; for review of focal adhesion structure and function, see Critchley, 2000) . Cas becomes phosphorylated in response to integrin engagement by a wide variety of ECM components, including ®bronectin (FN), vitronectin, laminin and collagen Nojima et al., 1995; Polte and Hanks, 1997; Vuori and Ruoslahti, 1995) . c-Src and other Src family kinases, as well as focal adhesion kinase (Fak) and its close relative Pyk2 (also known as cell adhesion kinase b; CAKb), have been implicated in integrindependent phosphorylation of Cas (Hamasaki et al., 1996; Klinghoer et al., 1999; Schlaepfer et al., 1997; Tachibana et al., 1997; Ueki et al., 1998; Vuori et al., 1996) .
There is considerable evidence to suggest that Cas plays a role in cytoskeletal regulation and cell adhesion. Perhaps the most compelling data come from studies using ®broblasts isolated from embryos containing a targeted disruption of the cas gene. Cas 7/7 cells contain disorganized, short actin ®laments relative to the normal actin stress ®ber organization exhibited by analogous cells that have been engineered to express ectopic Cas (Honda et al., 1998 (Honda et al., , 1999 . However, Cas does not appear to be required for focal adhesion formation, since both Cas 7/7 and Cas +/+ cells show normal levels of vinculin staining of focal adhesions (Honda et al., 1998) .
During the process of cell migration, actin stress ®bers undergo dissolution and reformation. Consequently, it is not surprising that Cas and other focal adhesion proteins play a role in cell migration. Casde®cient ®broblasts show decreased haptotaxis toward FN, a decreased ability to migrate into the gap in a wound healing assay, and decreased basal and seruminduced invasion through a 3-dimensional collagen matrix (Cho and Honda et al., 1999) . This reduced migratory phenotype is similar to that observed for FN-, Fak-and Src-de®cient ®broblasts (George et al., 1993; Hamasaki et al., 1996; Ilic et al., 1995; Klinghoer et al., 1999; Owen et al., 1999) , suggesting that these molecules may function in a common pathway to promote migration.
In many cases, migration can be correlated with increased tyrosine phosphorylation of Cas. Src/Yes/ Fyn (SYF)-de®cient ®broblasts, which show decreased levels of adhesion-dependent Cas phosphorylation, exhibit marked defects in cell migration (Klinghoer et al., 1999) . Fibroblasts that overexpress the protein tyrosine phosphatase (PTPase) PTP-PEST also demonstrate defects in cell migration that coincide with signi®cantly reduced levels of tyrosine phosphorylated Cas (Garton and Tonks, 1999) . Finally, expression of the dual-speci®city phosphatase PTEN inhibits cell migration and invasion through a process that involves dephosphorylation of Fak and Cas (Tamura et al., 1999) . When either Fak or Cas is co-expressed with PTEN, phosphorylation of these molecules increases and PTEN-induced inhibition of migration and invasion is reversed.
The close functional relationship between Fak and Cas likely contributes to the role of Cas in cell migration. Cas and Fak colocalize in focal adhesions Hanks, 1995, 1997) and, as discussed above, Cas can be a substrate of Fak. Cary et al. (1996 Cary et al. ( , 1998 showed that overexpression of Fak in Chinese Hamster Ovary (CHO) cells enhances FN-mediated haptotaxis and that this eect can be inhibited by co-expression of the Cas SH3 domain. Under these conditions, it is thought that the Cas SH3 domain eectively competes for endogenous Cas in binding to Fak, thus inhibiting functional interactions between Fak and full-length Cas.
Cas also plays a role in migration through its association with Crk. Integrin-dependent phosphorylation of Cas often results in the establishment of CasCrk complexes (Cheresh et al., 1999; Garton and Tonks, 1999; Klemke et al., 1998; Mielenz et al., 2001; Vuori et al., 1996) . The role of these complexes in cell migration was directly established in a study by Klemke et al. (1998) which showed that Cas overexpression could enhance cell migration of COS and FG-M pancreatic carcinoma cells plated on vitronectin. Expression of a substrate binding domain deletion of Cas that is de®cient for Crk binding inhibited this eect. By expressing putative downstream molecules, the authors concluded that this migration pathway involved Cas, CrkII and Rac1. Cas-Crk signaling also appears to be important for haptotaxis involving ECM components other than vitronectin. For example, cells expressing a mutant of the a 7 integrin subunit exhibit diminished Cas phosphorylation and Cas-Crk association that coincides with decreased migration on the ECM component laminin (Mielenz et al., 2001) . The Cas-Crk pathway has also been shown to be important for chemotaxis induced by insulin, epidermal growth factor (EGF) and serum (Cheresh et al., 1999; Cho and Klemke, 2000; Klemke et al., 1998) .
In many cases, Cas-Crk complexes function to promote cytoskeletal rearrangements through activation of Rac1. Molecules that may link Cas-Crk interactions to Rac1 activation include C3G and DOCK180 (Arai et al., 1999; Kiyokawa et al., 1998a,b; Matsuda et al., 1996; Tanaka et al., 1994) . Interestingly, Cas-dependent cell migration pathways may not involve actin-myosin contraction, as indicated by the ®nding that a mutant form of Cas that blocks insulin-induced membrane ruing and migration has no eect on myosin light chain phosphorylation and cellular contraction in a 3-dimensional collagen matrix (Cheresh et al., 1999) .
Growth regulation
As discussed above, focal adhesion proteins can regulate cell adhesion to the ECM and migration. However, these same proteins also play a role in cell cycle progression and proliferation by transmitting growth and survival signals from the ECM (for review, see Aplin and Juliano, 1999; Giancotti, 1997; Howe et al., 1998) . A number of studies suggest that Cas, through interactions with its binding partners Fak, Src and Crk, is involved in this process.
The requirement for cells to adhere in order to progress through the cell cycle is ®rmly established for many cells (Aplin and Juliano, 1999; Giancotti, 1997; Howe et al., 1998) . However, upon entry into mitosis, cells detach from the ECM and remain detached until cytokinesis is complete. This suggests that there must be mechanisms in place during mitosis that promote disruption of cell adhesions and temporarily prevent reattachment. During mitosis, Cas, Fak and the focal adhesion protein paxillin become phosphorylated on serine (Ser) and threonine (Thr) residues, and are concomitantly dephosphorylated on tyrosine residues (Yamakita et al., 1999) . Furthermore, levels of FakCas and Fak-Src complexes are signi®cantly reduced during mitosis. Re-entry into the G1 phase of the cell cycle is accompanied by a loss of Ser/Thr phosphorylation, a return to normal levels of Fak, Cas and paxillin tyrosine phosphorylation, a restoration of FakCas and Fak-Src protein complexes, and reattachment to the ECM.
One downstream consequence of integrin-mediated cell adhesion is activation of the Jun NH 2 -terminal kinase (JNK), leading to phosphorylation of its target c-jun and regulation of AP-1-dependent transcription. JNK activation in response to cell adhesion may therefore be an important factor in cell cycle progression (Oktay et al., 1999) . Expression of dominant-negative Fak variants inhibits integrin-dependent JNK activation, indicating that Fak plays an important role in this process. Expression of a Cas mutant lacking the substrate-binding YXXP domain is also inhibitory for JNK activation and cell cycle progression, implicating Cas in these processes as well. It has been proposed that protein complexes containing Fak, Src and Cas recruit the small adapter protein Crk in order to promote JNK activation and cell proliferation. The requirement for Fak-Cas interactions in cell proliferation is supported by a second study, which showed that G1 progression and DNA synthesis requires the direct association of Fak and Cas (Reiske et al., 2000) . In this case, expression of a Fak molecule de®cient for Cas binding was found to decrease 5-Bromo-2'deoxy-uridine (BrdU) incorporation by 50%.
There is also evidence in support of a role for SrcCas interactions in cell proliferation. Overexpression of Oncogene Functions of the adapter protein Cas AH Bouton et al Cas in C3H10T1/2-5H cells that stably overexpress cSrc (Wilson and Parsons, 1990) , and the ensuing accumulation of Src-Cas complexes, correlates with an increase in BrdU incorporation under serum-free conditions and a marked enhancement of anchorageindependent growth (Burnham et al., 2000) . Because Cas binding to Src serves to increase the enzymatic activity of Src, it has been proposed that the enhanced ability of these cells to grow in a serum-and ECMindependent fashion may stem from an overall increase in Src activity.
From these data, it appears that Cas can function to regulate progression through the cell cycle, both by transmitting survival signals from the ECM and by modulating Src kinase activity. The Cas family member HEF1 appears to have a dierent role in cell cycle progression. Unlike Cas, which is expressed at relatively equivalent levels throughout the cell cycle, HEF1 expression levels are low in quiescent cells and increase following induction of cell growth by either serum or release from thymidine block (Law et al., 1998) . The levels of full-length HEF1 then undergo a dramatic decrease at the onset of mitosis. The appearance of a 55 kDa amino-terminal fragment of HEF1 (p55) coincides with this decrease in the fulllength molecule. Immuno¯uorescence studies showed that p55 is localized to the mitotic spindle from prophase to late anaphase, and it localizes to the midbody during cytokinesis. Interestingly, a yeast twohybrid screen identi®ed Dim1p as a binding partner of HEF1 (Law et al., 1996) . This protein is essential for passage through the G2/M checkpoint in Saccharomyces pombe. While further analysis is required to fully understand the role of p55 HEF1 in cell cycle progression, it appears that this Cas family member has a unique function in cell proliferation, one that may involve transmission of pro-proliferative signals directly to the mitotic spindle.
Apoptosis
The ECM also provides an important survival signal to adherent cells (for review, see Frisch and Ruoslahti, 1997; Howe et al., 1998) . Thus the presence of Cas in focal adhesions and its potential role in integrin signaling may contribute to cell survival and the prevention of apoptosis. The precise molecular mechanism by which Cas might mediate these eects is not yet clear, although evidence points toward a role for Fak-Cas, Src-Cas and/or Cas-Crk protein complexes. For example, in rabbit synovial ®broblasts, prosurvival signals emanating from the ECM proceed through Fak to Cas and require the small GTPases Ras and Rac1 as well as activation of JNK2 (Almeida et al., 2000) . Phosphorylation of Cas and its ability to associate with Fak are essential steps in this survival pathway. Similarly, treatment of cells with reactive oxygen species (ROS) induces JNK activation through a pathway that involves Src and Cas (Yoshizumi et al., 2000) .
Cytoskeletal and adhesive changes that accompany programmed cell death are often associated with cleavage of a number of cytoskeletal regulatory proteins, including Cas, Fak, paxillin and Src (Chan et al., 1999; Kook et al., 2000b) . Multiple proapoptotic stimuli have been shown to induce Cas cleavage, including Eschericia coli lipopolysaccharide (LPS), nocodazole, etoposide, adenosine and UV irradiation (Bannerman et al., 1998; Chan et al., 1999; Harrington et al., 2001; Kook et al., 2000a,b) . Cas dephosphorylation, Cas cleavage and apoptosis are also induced by overexpression of the receptor-like PTPase LAR (Weng et al., 1999) . Several lines of evidence indicate that caspases are responsible for Cas cleavage following treatment with these apoptosisinducing agents. First, caspase-3 can directly cleave Cas in vitro and caspase inhibitors prevent cleavage of Cas in vivo (Kook et al., 2000a) . Second, Cas cleavage is prevented when a consensus caspase cleavage site on Cas is mutated. The functional signi®cance of this modi®cation is suggested by the ®nding that etoposidedependent Cas cleavage correlates with a loss of focal adhesions, and that focal adhesions are maintained in the presence of a Cas mutant that lacks the consensus caspase cleavage site (Kook et al., 2000a) .
Cleavage of Cas during apoptosis and the accompanying changes in focal adhesion architecture may serve to prevent transmission of survival signals from the ECM. Several studies support the idea that Cas is an important transmitter of survival signals. FG-M pancreatic adenocarcinoma cells show increased survival as compared to the nonmetastatic FG cell line from which they were selected (Cho and Klemke, 2000; Klemke et al., 1998) . FG-M cells contain an increased number of Cas-Crk complexes and disruption of these complexes promotes apoptosis. Cas-Crk complexes also promote invasion and survival in COS-7 cells, both of which are blocked by expression of a dominant-negative form of Rac1. These data indicate that the Cas-Crk-Rac1 pathway that was established for cell migration is also important for transmission of survival signals emanating from the ECM.
The Cas family member HEF1 has a somewhat dierent role in programmed cell death. Whereas increased Cas expression can result in protection from apoptosis (Cho and Klemke et al., 1998; Weng et al., 1999) , overexpression of HEF1 in MCF-7 human breast cancer cells leads to increased apoptosis (Law et al., 2000) . Endogenous HEF1 is cleaved in MCF-7 cells in a caspase-dependent manner upon induction of apoptosis by TNF-a. The carboxyterminal 28 kDa cleavage product has been shown to be both necessary and sucient to promote programmed cell death (Law et al., 2000) . These data implicate a pro-apoptotic function within the extreme carboxy-terminus of HEF1, which shares considerable sequence homology with Cas. Interestingly, Cas cleavage during apoptosis also produces a 28-kDa carboxy-terminal fragment but there is no evidence that this fragment is capable of inducing apoptosis (Law et al., 2000) . Further research is needed to determine if Cas, and possibly Efs/Sin, can promote apoptosis upon cleavage.
Microbial pathogenesis
In addition to its function in signaling pathways that regulate cell adhesion, migration, proliferation and survival, the actin cytoskeleton also plays an important role in a myriad of host-pathogen interactions (for review, see Frischknecht and Way, 2001 ). For example, phagocytosis of Yersinia pseudotuberculosis is largely initiated by a mechanism that involves many of the same proteins that regulate cell migration. Y. pseudotuberculosis expresses a surface protein, termed invasin, that binds with high anity to b 1 integrins present on the surface of host cells Isberg et al., 2000) . As is the case for integrin engagement by ECM components, invasin-b 1 interactions induce the activation of cellular PTKs and downstream signaling cascades. This results in a dramatic rearrangement of the actin cytoskeleton that accompanies bacterial uptake and clearance. Pathogenic Yersiniae have developed a mechanism to remain extracellular by expressing virulence proteins that block these cellular signaling pathways and thereby inhibit phagocytosis. A role for Cas in bacterial internalization was ®rst suggested when two laboratories reported that Cas is a substrate of an antiphagocytic eector of Y. pseudotuberculosis, the PTPase YopH (Black and Bliska, 1997; Persson et al., 1997) . The antiphagocytic function of YopH is believed to be due to its ability to dephosphorylate focal adhesion proteins such as Cas, Fak and paxillin, thereby preventing cytoskeletal rearrangements and inhibiting signaling pathways that lead to bacterial uptake (Black and Bliska, 1997; Black et al., 1998; Persson et al., 1997) .
Y. pseudotuberculosis strains that do not express YopH are eciently internalized by a wide range of mammalian cells (Andersson et al., 1996; Black and Bliska, 1997; Persson et al., 1997) . The requirement for Cas function in the process of Yersinia uptake was established through the expression of a variant of Cas that contains a deletion of the substrate-binding YXXP domain. Expression of this molecule was found to inhibit the uptake of Yersinia strains that do not express YopH . Further characterization of the Cas-dependent pathway of Yersinia uptake placed Crk and Rac1 downstream of Cas and also implicated additional binding partners of Crk. Perhaps not surprisingly, this pathway is similar to the Cas-dependent pathway that is involved in aspects of cell migration .
Interestingly, studies investigating Adenovirus internalization showed that overexpression of a Cas mutant containing a similar deletion of the substrate-binding YXXP domain also inhibits Adenovirus entry into host cells (Li et al., 2000) . Adenovirus internalization is initiated when surface penton proteins bind to host cell a 7 integrins (Mielenz et al., 2001) . As is the case for invasin-b 1 integrin binding, the interaction between Adenovirus proteins and a 7 integrins induces tyrosine phosphorylation of Cas (Li et al., 2000) . Treatment of cells with PTK inhibitors both inhibits Cas phosphorylation and results in decreased viral internalization, indicating that PTK activity and perhaps speci®cally Cas phosphorylation are important events in the process of viral endocytosis. Although speci®c Casdependent mechanisms for Adenovirus uptake have not been identi®ed, infection has been shown to promote an association between Cas and the p85 subunit of phosphatidylinositol-3 kinase (PI3K) (Li et al., 2000) . Overexpression of a Cas construct in which the carboxy-terminal PI3K binding site is mutated inhibits Adenovirus uptake, suggesting that the association of PI3K and Cas may be critical for ecient Adenovirus endocytosis.
In light of these studies, it is clear that internalization of pathogens that bind to integrin receptors can be initiated through PTK-dependent signaling pathways that promote rearrangements of the actin cytoskeleton coincident with uptake. The demonstration that endocytosis of intracellular microorganisms such as Adenovirus involves Cas, and that Cas is a target of eectors designed to inhibit phagocytosis of extracellular pathogens such as Y. pseudotuberculosis, highlights its important function in these processes. Although its precise role is not well understood, the ability of Cas to either directly or indirectly modulate the function and activities of molecules such as Crk, Rac1, PI3K and Src is likely to be critical for its function in microbial pathogenesis as well as in migration.
Cancer
Deregulation of the signaling pathways that control cell adhesion, migration, survival and proliferation can result in oncogenic transformation and metastasis. Consequently, molecules such as Cas that participate in multiple facets of these processes are likely to play a critical role in oncogenesis. In fact, Cas was ®rst identi®ed as a molecule whose phosphorylation correlated with transformation by the v-Src and vCrk oncoproteins (Matsuda et al., 1990; Reynolds et al., 1989) . Studies using Cas-null ®broblasts provide strong evidence that Cas is required for Src transformation (Honda et al., 1998) . In the absence of Cas expression, mouse embryo ®broblasts were shown to be resistant to transformation by constitutively active Src. The ability of activated Src to induce morphological transformation and anchorage-independent growth was restored when wild type Cas was ectopically expressed in the Cas-null cells. Furthermore, Auvinen et al. (1995) demonstrated that expression of antisense Cas constructs could partially reverse cellular transformation induced by ornithine decarboxylase, Ha-Ras and v-Src, indicating that Cas plays a direct role in cellular transformation.
Although the precise mechanism by which Cas participates in Src-mediated transformation is not known, the direct interaction between Cas and Src appears to be important for this process. In Rat 1-LA29 cells, which express a temperature-sensitive vSrc allele, Cas is tyrosine phosphorylated and associates with Src only at permissive temperatures (Burnham et al., 1999) . When the carboxy-terminus of Cas (Cas-CT) was ectopically expressed in these cells, the transformed phenotype was maintained despite the fact that v-Src-Cas complexes were replaced by v-SrcCas-CT complexes. This suggests that Cas-CT, which contains the bipartite Src-binding sequence, can functionally substitute for full length endogenous Cas in this process.
Src-Cas complexes may function to promote transformation through the modulation of Src activity.
In support of this model, a dramatic increase in Src PTK activity is observed upon Src binding to either full length Cas or Cas-CT (Burnham et al., 2000) . The biological signi®cance of this activation is suggested by studies that examined the growth properties of stable cell lines that overexpress Src and either full length Cas or Cas-CT. These cells, which contain elevated levels of Src-Cas or Src-Cas-CT protein complexes, exhibited enhanced serum-and anchorage-independent growth.
Numerous events occur downstream of Src catalytic activation that may be impacted by Cas. For example, v-Src expression results in the transcriptional activation of a set of immediate early genes that are controlled by serum response elements (SREs) (Meijne et al., 1997) . Hakak and Martin showed that coexpression of Cas with v-Src enhanced transcription from these sites. These investigators went on to demonstrate that Src-dependent SRE activation involved Cas binding to Src, the establishment of Grb2-Shc and Grb2-Shp2 complexes, and activation of the Ras/MEK/Erk signaling cascade (Hakak and Martin, 1999) .
Like Cas, Efs/Sin can bind to, and activate, c-Src (Alexandropoulos and Baltimore, 1996; Xing et al., 2000) . Using transcription from the SRE as a read-out for c-Src activation, the Src-Efs/Sin protein complex was shown to activate the small GTPase Rap1 through a pathway that involves the adapter protein Crk and its association with the Rap1 exchange factor C3G (Xing et al., 2000) . GTP-bound Rap1, in turn, mediates activation of the SRE through the ERK pathway.
Taken together, these data support a model in which the association of Cas or its family members with c-Src activates PTK activity, leading to increased tyrosine phosphorylation of Src substrates, activation of downstream signaling pathways, and cell proliferation. When spatially and temporally controlled, this process may contribute to normal growth regulation. However, when modulation of Src activity by Cas becomes deregulated as a consequence of increased protein expression or prolonged signaling of the SrcCas complex, this pathway may result in enhanced growth and survival in the absence of growth factors and/or the ECM. In this way, the Src-Cas complex may not only regulate aspects of normal cell proliferation, but it may also promote unregulated growth and survival, which are hallmarks of cellular transformation.
It is therefore not surprising that there is evidence suggesting Cas involvement in the initiation and/or progression of human cancers. Retroviral insertion mutagenesis of the estrogen receptor-positive ZR-75-1 human breast cancer cell line resulted in the identi®ca-tion of three loci that promote tamoxifen resistance when they become upregulated (Brinkman et al., 2000) . The breast cancer anti-estrogen resistance 1 (BCAR1) locus was subsequently identi®ed as the human homologue of Cas. When Cas was stably transfected into ZR-75-1 cells, it conferred the ability to proliferate in the presence of either tamoxifen or the anti-estrogen ICI 182,780. This coincided with Cas-dependent alterations in cell morphology and cytoskeletal architecture. Moreover, high levels of Cas expression in breast tumors correlated with decreased patient survival and poor response to tamoxifen therapy (van der Flier et al., 2000a) . Although high Cas expression did not correlate with the acquisition of tamoxifen resistance, it was found to be a signi®cant risk factor for the roughly 40% of breast tumors that exhibit intrinsic tamoxifen resistance (Foekens et al., 1994; van der Flier et al., 2000b) .
The mechanism by which Cas promotes tamoxifen resistance in breast tumors has yet to be elucidated. An attractive hypothesis, based on the in vitro data presented above, is that increased expression of both Cas and c-Src could result in increased levels of SrcCas complexes, leading to elevated Src activity and enhanced cell growth. In fact, 25 ± 30% of breast tumors exhibit elevated c-Src mRNA and protein levels, which correlate with increased Src activity in the absence of activating mutations of Src (Biscardi et al., 1998; Koster et al., 1991; Verbeek et al., 1996) . Many of the breast cancer cell lines that exhibit increased c-Src activity also express high levels of Cas and Src-Cas complexes (data not shown). The potential contribution of these complexes to the growth, progression and perhaps tamoxifen resistance of breast tumors remains to be determined.
The involvement of Cas and its family members in other human cancers remains an important question to address. Recent evidence suggests that growth and invasion of malignant melanoma cells can be accompanied by increases in Cas tyrosine phosphorylation (Eisenmann et al., 1999; Schraw and Richmond, 1995) . Cas and its family members may also play a role in the development or progression of certain leukemias. Cells expressing p190 BCR/ABL , the causative agent of Philadelphia-positive acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML), contain high levels of tyrosine phosphorylated Cas and HEF1 coincident with the presence of Cas/HEF1-Crk protein complexes (Dejong et al., 1997; Salgia et al., 1996) . Further studies are needed to de®ne how the Cas family of proteins functions in the initiation and/or progression of human cancer.
Cas phosphorylation and its binding partners: functional implications
While adhesion-dependent tyrosine phosphorylation of Cas has been extensively discussed above, activation of a wide range of other cellular receptors also results in Cas phosphorylation (see Table 1 ). These include receptor PTKs, G-protein coupled receptors (GPCRs) and hormone receptors (representative references include Casamassima and Rozengurt, 1997 Ferris et al., 1999; Larsson et al., 1999; Murakami et al., 1999; Needham and Rozengurt, 1998; Ojaniemi and Vuori, 1997; Ribon and Saltiel, 1996; Spencer et al., 2000; Takahashi et al., 1998; Zhu et al., 1998) . The pathways leading from these dierent receptors to Cas phosphorylation have both common and unique features; this complexity is undoubtedly an important feature of the biological function of Cas. The nature of both the ligand and activated receptor is likely to determine the speci®c signaling pathways that lead to PTK activation and Cas phosphorylation. This can explain why PI3K, for example, appears to be required for Cas phosphorylation in response to platelet-derived growth factor (PDGF) treatment but not in response to activation of GPCRs (Casamassima and Rozengurt, 1997) .
To date, four non-receptor PTKs have been shown to phosphorylate Cas in vitro: Src, Fak, Pyk2 and Abl (Astier et al., 1997a; Mayer et al., 1995; Sakai et al., 1994a; Tachibana et al., 1997) . As mentioned above, Src is considered to be predominantly responsible for integrin-dependent Cas phosphorylation (Hamasaki et al., 1996; Vuori et al., 1996) . In certain cases, Fak has also been shown to phosphorylate Cas in vivo (BruceStaskal and Bouton, 2001; Schlaepfer et al., 1997) . Because the induction of Fak phosphorylation and catalytic activity often accompanies Cas phosphorylation, Fak may play a central role in many cases of agonist-induced tyrosine phosphorylation of Cas (for example, see Bruce-Staskal and Bouton, 2001; Nakamura et al., 1998; Zachary et al., 1993) .
Tyrosine phosphorylation of Cas serves two known functions. First, it coincides with a relocalization of Cas from cytoplasmic to membrane-associated cell fractions (Sakai et al., 1994a) . Second, it promotes interactions with SH2-containing proteins. One phosphorylation-dependent interaction that is observed following receptor activation involves Cas and Src. The possible functions of Src-Cas interactions have been explored in great detail above. The second such interaction, which has perhaps been most frequently implicated in Cas function, involves Cas and Crk. The SH2 domain of Crk has the potential to bind to multiple pTyr residues present within the substratebinding YXXP domain of Cas. As described above, Cas-Crk signaling is critical for cell migration and internalization of the bacterial pathogen Y. pseudotuberculosis (Cho and Klemke et al., 1998; Weidow et al., 2000) . In these cases, Cas appears to function as a regulator of Crk, allowing it to interact with downstream eectors that ultimately promote activation of the small GTP-binding protein Racl. In this regard, Cas may be instrumental in localizing Crk and its associated proteins to regions of the cell where activation of Racl may be particularly important, such as membrane rues at the leading edge of the cell . One of the downstream eects of Cas-Crk-Racl signaling appears to be JNK activation (Dol® et al., 1998) . Cas may also play a role in regulating Crk binding to other signaling molecules. For example, Crk has been found to shuttle from CasCrk complexes to Crk-Gab, Crk-Cbl or Crk-insulin receptor substrate 1 (IRS-1) complexes in response to certain signals (Khwaja et al., 1996; Lamorte et al., 2000; Sorokin and Reed, 1998) . By controlling the nature and dynamics of Crk-dependent downstream signaling pathways, Cas can eectively impact a wide range of cellular responses.
With the exception of Src and Crk, the function of interactions between Cas and the large array of possible binding partners remains largely undetermined. However, recent data have shed some light on possible functions of a third Cas complex, which contains members of the Nsp family of proteins (Nsp1; Nsp2/BCAR3/AND-34 (AND-34); and Nsp3/Chat/ SHEP1 (Chat) (Cai et al., 1999; Dodelet et al., 1999; Gotoh et al., 2000; Lu et al., 1999; Sakakibara and Hattori, 2000; van Agthoven et al., 1998) . These proteins share a common structural organization, characterized by an amino-terminal SH2 domain, a central proline-rich domain and a carboxy-terminal guanine nucleotide exchange factor (GEF) domain that has been shown in at least one instance to have activity for Ra1A, Rap1A and R-Ras (Gotoh et al., 2000) . Both Cas (BCAR1) and AND-34 (BCAR3) were isolated from the same genetic screen that was designed to isolate genes that conferred upon cells the ability to grow in the presence of tamoxifen, strongly suggesting that they function in a common growth-regulatory pathway (Brinkman et al., 2000; van Agthoven et al., 1998) . All three Nsp family members have been shown to bind to Cas (Cai et al., 1999; Gotoh et al., 2000; Lu et al., 1999; Sakakibara and Hattori, 2000) . In most cases, this interaction appears to involve sequences within the carboxy-terminal GEF domain of the Nsp proteins and carboxy-terminal sequences of Cas that are distinct from the Src binding sites. Although CasNsp interactions appear to be largely constitutive, Nsp phosphorylation is induced by a variety of growth factors (Cai et al., 1999; Lu et al., 1999; Sakakibara and Hattori, 2000) . Following EGF treatment, both Cas and Chat relocalize to membrane rues, suggesting that they may function coordinately at these sites (Sakakibara and Hattori, 2000) . Additional indications that Cas and Nsp functions may be linked comes from studies that focused on the GEF activity of AND-34 (Gotoh et al., 2000) . These investigators demonstrated that the RalA GEF activity of AND-34 was inhibited by overexpressed Cas and that inhibition required Cas-AND-34 association. Although functions for the majority of Cas protein complexes still remain to be determined, it is clear that early predictions about Cas serving as a scaolding protein have stood the test of time. The ability to undergo rapid changes in phosphorylation, subcellular localization, and association with heterologous proteins provides Cas with the means to both spatially and temporally regulate the function of its numerous binding partners. It remains to be determined how this molecule serves as a point of convergence for so many distinct signaling inputs and how it ultimately contributes to the generation of speci®c cellular responses.
